Receptor Binding in Drug Discovery and Development

互联网2014-02-10

431

The ultimate goal of any drug development program is the application of basic research, both chemical and biological, to the discovery of therapeutic modalities that can prevent, alleviate, or cure the malfunctions in the mammalian homeostatic mechanism that lead to the disease state.

相关产品推荐

nfsA/nfsA蛋白Recombinant Escherichia coli Oxygen-insensitive NADPH nitroreductase (nfsA)重组蛋白Modulator of drug activity A蛋白

￥2328

CALCOCO2/CALCOCO2蛋白/(Antigen nuclear dot 52 kDa protein)(Nuclear domain 10 protein NDP52)(Nuclear domain 10 protein 52)(Nuclear dot protein 52)蛋白/Recombinant Human Calcium-binding and coiled-coil domain-containing protein 2 (CALCOCO2)重组蛋白

￥69

AMFR/AMFR蛋白/(Autocrine motility factor receptor)(AMF receptor)(RING finger protein 45)(gp78)蛋白/Recombinant Human E3 ubiquitin-protein ligase AMFR (AMFR), partial重组蛋白

￥69

ABCC1抗体ABCC1一抗抗体Multiple drug resistance protein 1 antibody抗体ABCC1 Antibody抗体

￥1100

SUSD6抗体SUSD6兔多抗抗体Drug-activated gene overexpressed protein antibody抗体SUSD6 Antibody, FITC conjugated抗体

￥880